Recent trials highlight T-DXd's superior efficacy and manageable toxicity in treating high-risk HER2-positive breast cancer, reshaping treatment strategies.
Managed care organizations should evolve cost models to capture savings from dextromethorphan-bupropion’s safety profile, which avoids costly complications associated with traditional Alzheimer ...
Managed care organization and providers should conduct early formulary reviews and education to ensure rapid access to dextromethorphan-bupropion upon approval, potentially delaying facility placement ...
The poster, presented by William Audeh, MD, MS, chief medical officer of Agendia, cited results from the MammaPrint, ...
To fully understand the burden of influenza, multiple factors must be considered, including prevention efforts, the ...
Multidisciplinary care enhances kidney health and cardiovascular outcomes, but more research into models is needed, said Roy ...
Peter Voorhees, MD, emphasizes the importance of carefully determined early regimens for smoldering myeloma and involving ...
Nimbus and Eli Lilly collaborate to develop an oral treatment for obesity, leveraging computational chemistry and structure-based drug design. Nimbus Therapeutics and Eli Lilly announce their ...
Food-insecure individuals have fewer total annual visits (in-person and via telehealth) across 4 types of office-based and outpatient visits: general checkup, diagnosis or treatment, psychotherapy or ...
Benefits of GLP-1 RAs were consistent across age groups and BMI categories, with semaglutide showing significant efficacy. These results were presented during the press briefing ahead of the 2026 ...
Explore the transformative potential of bispecific antibodies in multiple myeloma, offering hope for improved patient ...
Experts discuss the critical challenges in accessing innovative treatments for relapsed refractory multiple myeloma, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results